Our results support the hypothesis that an oxidative environment promoted through the absence of functional GSTM1 enzyme potently enhances the risk of ACPA positivity in RA conferred by the presence of HLA-DRB1 SE. The gene discussed is PRTN3; the disease is rheumatoid arthritis.